erlotinib hydrochloride has been researched along with Keratitis, Ulcerative in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, S | 1 |
| Nakamura, S; Ohira, A; Takai, Y; Tamura, M | 1 |
| Alfonso-Bartolozzi, B; Ciufo, G; Gil-Bazo, I; Guarnieri, A; Moreno-Montañés, J | 1 |
3 other study(ies) available for erlotinib hydrochloride and Keratitis, Ulcerative
| Article | Year |
|---|---|
Presumed erlotinib-induced bilateral corneal ulcers in a dog with lung tumor.
Topics: Animals; Cornea; Corneal Ulcer; Dog Diseases; Dogs; Erlotinib Hydrochloride; Lung Neoplasms; Male; Tears | 2023 |
A case report of pseudo-exfoliation syndrome with prolonged corneal epithelial regeneration because of erlotinib-induced unilateral corneal ulcer and anterior uveitis.
Topics: Acute Disease; Aged, 80 and over; Antineoplastic Agents; Cornea; Corneal Topography; Corneal Ulcer; Erlotinib Hydrochloride; Exfoliation Syndrome; Humans; Male; Neoplasms; Uveitis, Anterior | 2020 |
Plasma rich in growth factors for the treatment of rapidly progressing refractory corneal melting due to erlotinib in nonsmall cell lung cancer.
Topics: Aged; Antineoplastic Agents; Blood Transfusion, Autologous; Carcinoma, Non-Small-Cell Lung; Corneal Ulcer; Erlotinib Hydrochloride; Female; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms | 2017 |